User login
Article Type
              
          Changed
              Wed, 07/25/2018 - 13:43
          Table of Contents
- Thirteen Years and Still Growing: An AVAHO History
- Criteria for Use Updates for Enzalutamide, Daratumumab, Elotuzumab, Carfilzomib, and Ixazomib
- Lung Cancer Screening: Translating Research Into Practice
- Open Clinical Trials for Patients With Colorectal Cancer
- Treatment and Management of Patients With Prostate Cancer
- Cancer Care Collaborative Approach to Optimize Clinical Care
- Patient Knowledge of and Barriers to Breast, Colon, and Cervical Cancer Screenings: A Cross-Sectional Survey of TRICARE Beneficiaries
- Novel Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1
      
            
      
      
     
      
  
        
      
    
Publications
          
      Sections
          
      Table of Contents
- Thirteen Years and Still Growing: An AVAHO History
- Criteria for Use Updates for Enzalutamide, Daratumumab, Elotuzumab, Carfilzomib, and Ixazomib
- Lung Cancer Screening: Translating Research Into Practice
- Open Clinical Trials for Patients With Colorectal Cancer
- Treatment and Management of Patients With Prostate Cancer
- Cancer Care Collaborative Approach to Optimize Clinical Care
- Patient Knowledge of and Barriers to Breast, Colon, and Cervical Cancer Screenings: A Cross-Sectional Survey of TRICARE Beneficiaries
- Novel Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1
      
            
      
      
     
      
  
        
      
    
Table of Contents
- Thirteen Years and Still Growing: An AVAHO History
- Criteria for Use Updates for Enzalutamide, Daratumumab, Elotuzumab, Carfilzomib, and Ixazomib
- Lung Cancer Screening: Translating Research Into Practice
- Open Clinical Trials for Patients With Colorectal Cancer
- Treatment and Management of Patients With Prostate Cancer
- Cancer Care Collaborative Approach to Optimize Clinical Care
- Patient Knowledge of and Barriers to Breast, Colon, and Cervical Cancer Screenings: A Cross-Sectional Survey of TRICARE Beneficiaries
- Novel Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1
      
            
      
      
     
      
  
        
      
    
Publications
          
      Publications
          
      Article Type
              
          Sections
          
      Citation Override
              Fed Pract. 2017 May;33(suppl 3)
          Disallow All Ads
              
          Content Gating
              No Gating (article Unlocked/Free)
          Alternative CME
              
          Consolidated Pubs: Do Not Show Source Publication Logo
              
          Use ProPublica
              
          